Trademark: 79204071
Word
LEADING THE GLAUCOMA JOURNEY
Status
Dead
Status Code
709
Status Date
Friday, March 22, 2024
Serial Number
79204071
Registration Number
5278988
Registration Date
Tuesday, September 5, 2017
Mark Type
3000
Filing Date
Tuesday, December 6, 2016
Published for Opposition
Tuesday, June 20, 2017
Cancellation Date
Friday, March 22, 2024

Trademark Owner History
Novartis AG - Original Registrant

Classifications
41 Training services, namely, organization of seminars in the field of eye health and publication of course materials in connection therewith
The mark consists of four connecting tear drops next to the words "LEADING THE GLAUCOMA JOURNEY".
Color is not claimed as a feature of the mark.
"GLAUCOMA"

Trademark Events
Mar 22, 2024
Cancelled Section 71
Sep 5, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 19, 2018
Final Decision Transaction Processed By Ib
Dec 18, 2017
Final Disposition Notice Sent To Ib
Dec 18, 2017
Final Disposition Processed
Dec 5, 2017
Final Disposition Notice Created, To Be Sent To Ib
Sep 5, 2017
Registered-Principal Register
Jun 20, 2017
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2017
Published For Opposition
May 31, 2017
Notification Of Notice Of Publication E-Mailed
May 12, 2017
Approved For Pub - Principal Register
Apr 29, 2017
Refusal Processed By Ib
Apr 24, 2017
Teas/Email Correspondence Entered
Apr 24, 2017
Correspondence Received In Law Office
Apr 24, 2017
Teas Response To Office Action Received
Apr 20, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 20, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 10, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Apr 10, 2017
Refusal Processed By Mpu
Apr 8, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Apr 7, 2017
Non-Final Action Written
Apr 4, 2017
Application Filing Receipt Mailed
Mar 31, 2017
Assigned To Examiner
Mar 31, 2017
New Application Office Supplied Data Entered
Mar 30, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24